Zeria Pharmaceutical saw no growth in patent filings in April and highest growth of 1.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.19%. GlobalData’s DataBook provides a comprehensive analysis of Zeria Pharmaceutical’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Zeria Pharmaceutical has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 50% grants. The United States(US), European Patent Office(EPO), and Canada(CA) patent Office are among the top ten patent offices where Zeria Pharmaceutical is filings its patents. Among the top granted patent authorities, Zeria Pharmaceutical has 50% of its grants in United States(US), 25% in European Patent Office(EPO) and 25% in Canada(CA).
Roche could be the strongest competitor for Zeria Pharmaceutical
Patents related to rare diseases lead Zeria Pharmaceutical's portfolio
Zeria Pharmaceutical has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Ileitis related patents lead Zeria Pharmaceutical portfolio followed by inflammatory bowel disease, and ulcerative colitis
Zeria Pharmaceutical has highest number of patents in ileitis followed by inflammatory bowel disease, ulcerative colitis. For ileitis, nearly 33% of patents were filed and 33% of patents were granted in Q2 2024.
For comprehensive analysis of Zeria Pharmaceutical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
